The Global Antiserum Market was valued at USD 978 Million in 2024 and is projected to reach USD 1.63 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period (2025–2032). This growth is being driven by increasing global incidence of infectious diseases, rising investments in biopharmaceutical R&D, and the accelerating adoption of advanced antiserum formulations like antitoxin, antibacterial, antiviral, and anti-Rh serums across laboratory diagnostics, clinical therapeutics, and research applications.

As the immunology and biopharmaceutical industry transforms toward precision medicine and rapid-response therapeutics, the spotlight is on the key antiserum manufacturers who are driving innovation, production efficiency, and accessible immunity solutions. In this blog, we profile the Top 10 Companies in the Global Antiserum Industry—a mix of biotech giants, diagnostic specialists, and research pioneers shaping the future of antiserum production and application.

---

🔟 1. FUJIFILM Wako Pure Chemical Corporation

Headquarters: Osaka, Japan
Key Offering: Antitoxin serum, Antibacterial serum, Antiviral serum

FUJIFILM Wako Pure Chemical Corporation stands out as a major player in the Asia-Pacific antiserum market, providing high-quality serums for clinical diagnostics and research. The company leverages its extensive manufacturing capabilities to supply freeze-dried antiserum formulations that ensure stability and efficacy, particularly in regions with challenging storage conditions. Their products support infectious disease testing and therapeutic interventions, serving hospitals, diagnostic centers, and research institutions worldwide.

Innovation Initiatives:

• Localized production facilities in Asia-Pacific for cost-effective supply
• Development of stable, freeze-dried antiserum products
• Customization for regional research and clinical needs

Download FREE Sample Report: Global Antiserum Market – View in Detailed Research Report

---

9️⃣ 2. Bethyl Laboratories

Headquarters: Montgomery, Texas, USA
Key Offering: Anti-Rh serum, Secondary antibodies, Antiserum for research

Bethyl Laboratories specializes in high-purity antisera for immunology research and diagnostics. With a focus on secondary antibodies and specialized serums, the company serves pharmaceutical companies and research institutions globally. Their products are integral to serological assays and contribute to advancements in understanding immune responses to pathogens.

Innovation Initiatives:

• High-purity antiserum production for precise diagnostics
• Support for autoimmune and infectious disease research
• Partnerships with academic institutions for serum-based studies

---

8️⃣ 3. OriGene Technologies

Headquarters: Rockville, Maryland, USA
Key Offering: Antiviral serum, Recombinant antibodies, Antiserum reagents

OriGene Technologies is recognized for its innovative antiserum products tailored for molecular biology and immunology applications. The company offers a broad portfolio including antiviral serums used in emerging infectious disease research, challenging established players with affordable and specialized solutions. Their reagents support high-throughput screening in diagnostic labs and contribute to faster pathogen detection.

Innovation Initiatives:

• Affordable antiserum alternatives for research
• Focus on emerging infectious diseases
• Integration of recombinant technologies

---

7️⃣ 4. Novacyt Group

Headquarters: Parsippany, New Jersey, USA (U.K. operations)
Key Offering: Antibacterial serum, Diagnostic antisera, Molecular diagnostics

Novacyt Group has gained traction as an emerging player in the antiserum market through its molecular diagnostic expertise combined with serum-based solutions. Operating primarily in Europe and North America, the company provides antisera for bacterial infection diagnostics, addressing antibiotic resistance challenges. Their strategic expansions are enhancing global availability of critical therapeutics.

Innovation Initiatives:

• Molecular diagnostics integrated with antiserum
• Focus on antibiotic-resistant infections
• Expansion through partnerships

Download FREE Sample Report: Global Antiserum Market – View in Detailed Research Report

---

6️⃣ 5. GD Animal Health

Headquarters: Deventer, Netherlands
Key Offering: Veterinary antisera, Antitoxin for animal health

GD Animal Health leads in veterinary antiserum applications, protecting livestock from infectious diseases. Their products are essential in poultry, cattle, and swine sectors, supporting the $1.4 trillion global livestock industry. The company addresses zoonotic disease concerns, bridging animal and human health.

Innovation Initiatives:

• Veterinary antiserum for livestock protection
• Zoonotic disease prevention
• Expansion into pet healthcare

---

5️⃣ 6. SSI Diagnostica

Headquarters: Hillerød, Denmark
Key Offering: Antitoxin serum, Tuberculin diagnostics, Antiserum for immunology

SSI Diagnostica excels in diagnostic antisera, particularly for tuberculosis and other bacterial infections. Based in Europe, they supply high-quality products to hospitals and diagnostic centers, emphasizing purity and specificity. Their contributions to global immunization programs are vital.

Innovation Initiatives:

• Specialized diagnostic antisera
• Tuberculosis and bacterial testing
• Compliance with EMA standards

---

4️⃣ 7. BD (Becton, Dickinson and Company)

Headquarters: Franklin Lakes, New Jersey, USA
Key Offering: Anti-Rh serum, Diagnostic reagents, Clinical antisera

BD is a dominant force in clinical diagnostics, offering anti-Rh serum critical for preventing complications in 1.5 million pregnancies annually. Their integrated solutions for hospitals and labs drive efficiency in serological testing, supporting infectious disease management worldwide.

Innovation Initiatives:

• Anti-Rh serum for maternal health
• Automation in diagnostic testing
• Broad clinical applications

---

3️⃣ 8. Bio-Rad Laboratories, Inc.

Headquarters: Hercules, California, USA
Key Offering: Antibacterial serum, Research antisera, Diagnostic kits

Bio-Rad Laboratories holds significant market share with antisera accounting for key segments in North America and Europe. Their high-purity products support over 30% of antibacterial serum demand, combating resistance through advanced research tools for labs and pharma companies.

Innovation Initiatives:

• High-purity antisera for resistance studies
• Diagnostic and research integration
• Strategic research partnerships

---

2️⃣ 9. Charles River Laboratories International, Inc.

Headquarters: Wilmington, Massachusetts, USA
Key Offering: Antiviral serum, Preclinical antisera, Immunology services

Charles River Laboratories maintains strong presence through continuous development of therapeutic antisera. Serving research institutions, they pioneer in preclinical testing and serum production, enhancing efficacy against viral threats like Ebola and Zika.

Innovation Initiatives:

• Preclinical antiserum development
• Viral outbreak response
• High-efficacy formulations

Download FREE Sample Report: Global Antiserum Market – View in Detailed Research Report

---

1️⃣ 10. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive antiserum portfolio, Antitoxin, Laboratory & clinical serums

Thermo Fisher Scientific Inc. leads the global antiserum market with its vast distribution network and diverse products for lab, clinical, and therapeutic use. Their 2023 acquisition strengthened immunology capabilities, dominating North America’s 38% share and driving innovations in purification and recombinant tech.

Innovation Initiatives:

• Extensive antiserum portfolio expansion
• Acquisitions in immunology
• Advanced bioprocessing for scalability

Read Full Report: Global Antiserum Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Antiserum Is Innovative and Accessible

The global antiserum market is undergoing a dynamic shift. While traditional animal-derived serums dominate, the industry is investing heavily in recombinant and synthetic alternatives, advanced production techniques, and expanded applications in diagnostics and veterinary medicine.

📈 Key Trends Shaping the Market:

• Rapid expansion in Asia-Pacific with 7.8% CAGR through 2032
• Regulatory approvals for novel formulations and blending mandates
• Digitalization of serological testing and AI-driven antibody development
• Pharma-biotech alliances for infectious disease response

Read Full Report: Global Antiserum Market – View in Detailed Research Report

The companies listed above are not only providing critical passive immunity—they’re spearheading the next-generation immunology transition.